Home›Grant Finder›Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
Sponsored by National Institutes of Health
Award
Varies — see funder site
Deadline
May 7, 2028
Geography
Open nationwide
Eligible organization types
Open to most organization types — confirm on funder site.